InvestorsHub Logo
Followers 76
Posts 3964
Boards Moderated 0
Alias Born 08/09/2004

Re: None

Friday, 01/08/2016 10:57:59 AM

Friday, January 08, 2016 10:57:59 AM

Post# of 399
Article...WINDSOR, ON / ACCESSWIRE / January 7, 2016 / The Wealthy Biotech Trader (or "WBT"), Akebia Therapeutics, Inc. (AKBA) is next on the list of interesting companies with high short positions prime for a "short squeeze". AKBA is a biopharmaceutical company, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Akebia has completed Phase 2 development of its lead product candidate, vadadustat (formerly AKB-6548), an oral therapy for the treatment of anemia related to CKD in both non-dialysis and dialysis patients.

BUY them when OVERSOLD..SELL them when OVERBOUGHT...don't chase them at the top!

All posts are my opinion only. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AKBA News